Lexaria Bioscience Corp. announced that on January 14, 2021, effective upon the closing of the Offering, Al Reese joined the board of directors of the company as an additional independent director. He was the Chief Financial Officer of a multi-billion public energy company and has directed over 50 acquisitions and financings ranging in size from several hundred thousand dollars to multibillion dollars. Mr. Reese was appointed to the company’s audit and finance committee, replacing Christopher Bunka, so that the audit committee will now have a financial expert and be comprised 100% of independent directors, with the other independent board members being Ted McKechnie and Nicholas Baxter. Mr. Reese was also appointed to the corporate governance and nominating committee, such committee also being comprised of independent directors Nicholas Baxter and Brian Quigley.